Literature DB >> 10799545

Evidence that Llck-mediated phosphorylation of p56dok and p62dok may play a role in CD2 signaling.

J G Némorin1, P Duplay.   

Abstract

The Lck tyrosine kinase is involved in signaling by T cell surface receptors such as TCR/CD3, CD2, and CD28. As other downstream protein-tyrosine kinases are activated upon stimulation of these receptors, it is difficult to assign which tyrosine-phosphorylated proteins represent bona fide Lck substrates and which are phosphorylated by other tyrosine kinases. We have developed a system in which Lck can be activated independently of TCR/CD3. We have shown that activation of an epidermal growth factor receptor/Lck chimera leads to the specific phosphorylation of Ras GTPase-activating protein (RasGAP) and two RasGAP-associated proteins, p56(dok) and p62(dok). Activation of the chimeric protein correlates with an increase in cellular Ca(2+) in the absence of ZAP-70 and phospholipase Cgamma1 phosphorylation. Furthermore, we have found that p62(dok) co-immunoprecipitates with the activated epidermal growth factor receptor/LckF505 and that phosphorylated Dok proteins bind to the Src homology 2 domain of Lck in vitro. In addition, we have shown that activation via the CD2 but not the TCR/CD3 receptor leads to the phosphorylation of p56(dok) and p62(dok). Using JCaM1.6 cells, we have demonstrated that Lck is required for CD2-mediated phosphorylation of Dok proteins. We propose that phosphorylation and Src homology 2-mediated association of p56(dok) and p62(dok) with Lck play a selective function in accessory receptor signal transduction mechanisms.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10799545     DOI: 10.1074/jbc.275.19.14590

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  7 in total

1.  The inositol 5-phosphatase SHIP-1 and adaptors Dok-1 and 2 play central roles in CD4-mediated inhibitory signaling.

Authors:  Paul M Waterman; Susanne Marschner; Erin Brandl; John C Cambier
Journal:  Immunol Lett       Date:  2012-02-24       Impact factor: 3.685

Review 2.  Introduction to DOK2 and its potential role in cancer.

Authors:  P Sun; R Li; Y Meng; S Xi; Q Wang; X Yang; X Peng; J Cai
Journal:  Physiol Res       Date:  2021-09-10       Impact factor: 1.881

3.  Phosphoinositide 3-kinase-dependent membrane recruitment of p62(dok) is essential for its negative effect on mitogen-activated protein (MAP) kinase activation.

Authors:  M Zhao; A A Schmitz; Y Qin; A Di Cristofano; P P Pandolfi; L Van Aelst
Journal:  J Exp Med       Date:  2001-08-06       Impact factor: 14.307

4.  Human T lymphotropic virus type-1 p30II alters cellular gene expression to selectively enhance signaling pathways that activate T lymphocytes.

Authors:  Bindhu Michael; Amrithraj M Nair; Hajime Hiraragi; Lei Shen; Gerold Feuer; Kathleen Boris-Lawrie; Michael D Lairmore
Journal:  Retrovirology       Date:  2004-11-23       Impact factor: 4.602

5.  Molecular signature of cell cycle exit induced in human T lymphoblasts by IL-2 withdrawal.

Authors:  Magdalena Chechlinska; Jan Konrad Siwicki; Monika Gos; Malgorzata Oczko-Wojciechowska; Michal Jarzab; Aleksandra Pfeifer; Barbara Jarzab; Jan Steffen
Journal:  BMC Genomics       Date:  2009-06-08       Impact factor: 3.969

6.  Dok-related protein negatively regulates T cell development via its RasGTPase-activating protein and Nck docking sites.

Authors:  Raffi Gugasyan; Cathy Quilici; Stacey T T I; Dianne Grail; Anne M Verhagen; Andrew Roberts; Toshio Kitamura; Ashley R Dunn; Peter Lock
Journal:  J Cell Biol       Date:  2002-07-01       Impact factor: 10.539

7.  BRK targets Dok1 for ubiquitin-mediated proteasomal degradation to promote cell proliferation and migration.

Authors:  Sayem Miah; Raghuveera Kumar Goel; Chenlu Dai; Natasha Kalra; Erika Beaton-Brown; Edward T Bagu; Keith Bonham; Kiven E Lukong
Journal:  PLoS One       Date:  2014-02-11       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.